Pacira BioSciences, Inc. PCRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2011-02-03
Pacira BioSciences, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 8,006,826 | $229.1M |
| D. E. Shaw & Co., Inc. | 1,982,724 | $44.8M |
| RENAISSANCE TECHNOLOGIES LLC | 1,825,501 | $41.3M |
| CITADEL ADVISORS LLC | 797,281 | $18.0M |
| TWO SIGMA INVESTMENTS, LP | 526,851 | $11.9M |
| AQR CAPITAL MANAGEMENT LLC | 154,298 | $3.5M |
| MILLENNIUM MANAGEMENT LLC | 57,031 | $1.3M |
Source: SEC EDGAR filings · CIK 0001396814 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.